Issued Patents All Time
Showing 1–22 of 22 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12409249 | Compositions and methods for immune tolerance | Sangeeta N. Bhatia, Arnav CHHABRA | 2025-09-09 |
| 12378297 | Chimeric antigen receptor T cells targeting the tumor microenvironment | Bryan Choi | 2025-08-05 |
| 12161668 | T cells expressing a chimeric antigen receptor | Bryan Choi | 2024-12-10 |
| 12049482 | Molecular switch-mediated control of engineered cells | Max Jan, Quinlan L. Sievers, Benjamin Ebert | 2024-07-30 |
| 11865167 | Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor | Jennifer Brogdon, Laura Alexandra Johnson, Carl H. June, Andreas Loew, John Scholler +1 more | 2024-01-09 |
| 11613574 | Methods and compositions relating to ex vivo culture and modulation of T cells | Felipe Bedoya | 2023-03-28 |
| 11578115 | Chimeric antigen receptors based on alternative signal 1 domains | Mark Cobbold, Irene Scarfo | 2023-02-14 |
| 11559589 | Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapy | Katherine A. High, Federico Mingozzi, Daniel Jeng-Ping Hui | 2023-01-24 |
| 11352434 | Chimeric antigen receptors targeting CD37 | Irene Scarfo | 2022-06-07 |
| 11332513 | Chimeric antigen receptors having GITR intracellular domain as co-stimulatory domain | Lijun Wu, Vita Golubovskaya | 2022-05-17 |
| 10927184 | Treatment of cancer using humanized anti-CD19 chimeric antigen receptor | Jennifer Brogdon, Carl H. June, Andreas Loew, John Scholler | 2021-02-23 |
| 10357514 | Treatment of cancer using anti-CD19 Chimeric Antigen Receptor | Carl H. June, David L. Porter, Mariusz A. Wasik, Saar Gill, Joseph A. Fraietta +11 more | 2019-07-23 |
| 10308717 | Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor | Jennifer Brogdon, Laura Alexandra Johnson, Carl H. June, Andreas Loew, John Scholler +1 more | 2019-06-04 |
| 10221245 | Treatment of cancer using humanized anti-CD19 chimeric antigen receptor | Jennifer Brogdon, Carl H. June, Andreas Loew, John Scholler | 2019-03-05 |
| 9453199 | Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool | Carl H. June, James L. Riley, Anna Kaskel, Robert Vonderheide | 2016-09-27 |
| 9394368 | Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor | Jennifer Brogdon, Laura Alexandra Johnson, Carl H. June, Andreas Loew, John Scholler +1 more | 2016-07-19 |
| 9075044 | Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapy | Katherine A. High, Federico Mingozzi, Daniel Jeng-Ping Hui | 2015-07-07 |
| 8637307 | Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool | Carl H. June, James L. Riley, Anna Thomas, Robert Vonderheide | 2014-01-28 |
| 7745140 | Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool | Carl H. June, James L. Riley, Anna Thomas, Robert Vonderheide | 2010-06-29 |
| 7670781 | Activation and expansion of T-cells using an agent that provides a primary activation signal and another agent that provides a co-stimulatory signal | James L. Riley, Carl H. June | 2010-03-02 |
| 7638325 | Activation and expansion of T-cells using an engineered multivalent signaling platform | Carl H. June, James L. Riley, Anna Thomas | 2009-12-29 |
| 7638326 | Activation and expansion of T-cells using an engineered multivalent signaling platform | Carl H. June, James L. Riley, Anna Thomas, Robert Vonderheide | 2009-12-29 |